Cargando…

Toll-like Receptor Agonists Are Unlikely to Provide Benefits in Head and Neck Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis

SIMPLE SUMMARY: Recurrent and metastatic head and neck cancer has limited treatment options and survival time is measured in months. Toll-like receptor agonists have been shown to improve tumor immune responses in preclinical studies and several clinical trials have now been performed. We performed...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maddineni, Sainiteesh, Chen, Michelle, Baik, Fred, Divi, Vasu, Sunwoo, John B., Finegersh, Andrey
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Systematic Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10486924/ https://www.ncbi.nlm.nih.gov/pubmed/37686661 http://dx.doi.org/10.3390/cancers15174386

Ejemplares similares

Emerging NK cell therapies for cancer and the promise of next generation engineering of iPSC-derived NK cells
por: Maddineni, Sainiteesh, et al.
Publicado: (2022)

Targeting Toll-like receptor 2 inhibits growth of head and neck squamous cell carcinoma
por: Farnebo, Lovisa, et al.
Publicado: (2015)

Sex Disparity for Patients with Cutaneous Squamous Cell Carcinoma of the Head and Neck: A Systematic Review
por: Tan, Brandon, et al.
Publicado: (2022)

Prognostic and Predictive Biomarkers in Head and Neck Squamous Cell Carcinoma Treated with Radiotherapy—A Systematic Review
por: Schanne, Daniel H., et al.
Publicado: (2022)

Patients with Pulmonary Metastases from Head and Neck Cancer Benefit from Pulmonary Metastasectomy, A Systematic Review
por: Schlachtenberger, Georg, et al.
Publicado: (2022)

DNA methylation regulates TMEM16A/ANO1 expression through multiple CpG islands in head and neck squamous cell carcinoma
por: Finegersh, Andrey, et al.
Publicado: (2017)

CD271 is a functional and targetable marker of tumor-initiating cells in head and neck squamous cell carcinoma
por: Murillo-Sauca, Oihana, et al.
Publicado: (2014)

Timing of postoperative oral feeding after head and neck mucosal free flap reconstruction
por: Stramiello, Joshua, et al.
Publicado: (2021)

Immune checkpoint inhibitors in head and neck squamous cell carcinoma: A systematic review of phase-3 clinical trials
por: Poulose, Jissy Vijo, et al.
Publicado: (2022)

Review of RM-1929 Near-Infrared Photoimmunotherapy Clinical Efficacy for Unresectable and/or Recurrent Head and Neck Squamous Cell Carcinoma
por: Miyazaki, Nanami L., et al.
Publicado: (2023)

Primary Extracranial Meningiomas of the Head and Neck
por: Umana, Giuseppe Emmanuele, et al.
Publicado: (2021)

Local Tumor Behavior Associated With Survival Among Patients With Paraganglioma of the Head and Neck
por: Harley, Randall J., et al.
Publicado: (2022)

Prognostic Significance of CD4+ and CD8+ Tumor-Infiltrating Lymphocytes in Head and Neck Squamous Cell Carcinoma: A Meta-Analysis
por: Borsetto, Daniele, et al.
Publicado: (2021)

The Prognostic Role of miR-31 in Head and Neck Squamous Cell Carcinoma: Systematic Review and Meta-Analysis with Trial Sequential Analysis
por: Dioguardi, Mario, et al.
Publicado: (2022)

Current Applications of Artificial Intelligence to Classify Cervical Lymph Nodes in Patients with Head and Neck Squamous Cell Carcinoma—A Systematic Review
por: Santer, Matthias, et al.
Publicado: (2022)

The Prediction of Biological Features Using Magnetic Resonance Imaging in Head and Neck Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis
por: van der Hulst, Hedda J., et al.
Publicado: (2023)

DRESS syndrome: an unlikely diagnosis with an unlikely cause
por: Soares, Sofia Garcês, et al.
Publicado: (2022)

Immunotherapy in Head and Neck Cancer When, How, and Why?
por: Pereira, Daniela, et al.
Publicado: (2022)

PD-L1 is preferentially expressed on CD44+ tumor-initiating cells in head and neck squamous cell carcinoma
por: Lee, Yunqin, et al.
Publicado: (2014)

Efficacy of Afatinib in the Treatment of Patients with Non-Small Cell Lung Cancer and Head and Neck Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis
por: Maarof, Nian N. N., et al.
Publicado: (2021)

Is the Non-Coding RNA miR-195 a Biodynamic Marker in the Pathogenesis of Head and Neck Squamous Cell Carcinoma? A Prognostic Meta-Analysis
por: Dioguardi, Mario, et al.
Publicado: (2023)

Predictive Value of EGFR-PI3K-AKT-mTOR-Pathway Inhibitor Biomarkers for Head and Neck Squamous Cell Carcinoma: A Systematic Review
por: de Kort, W. W. B., et al.
Publicado: (2021)

Biological Prognostic Value of miR-155 for Survival Outcome in Head and Neck Squamous Cell Carcinomas: Systematic Review, Meta-Analysis and Trial Sequential Analysis
por: Dioguardi, Mario, et al.
Publicado: (2022)

Antioxidant Use after Diagnosis of Head and Neck Squamous Cell Carcinoma (HNSCC): A Systematic Review of Application during Radiotherapy and in Second Primary Cancer Prevention
por: Meliante, Piero Giuseppe, et al.
Publicado: (2023)

Electrochemotherapy in Mucosal Cancer of the Head and Neck: A Systematic Review
por: Strojan, Primož, et al.
Publicado: (2021)

Milk-Derived Proteins and Peptides in Head and Neck Carcinoma Treatment
por: Wang, Theresa, et al.
Publicado: (2022)

Does miR-197 Represent a Valid Prognostic Biomarker in Head and Neck Squamous Cell Carcinoma (HNSCC)? A Systematic Review and Trial Sequential Analysis
por: Dioguardi, Mario, et al.
Publicado: (2022)

Comparison of Second-Line Treatments for Patients with Platinum-Resistant Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Systematic Review and Bayesian Network Meta-Analysis
por: He, Yan, et al.
Publicado: (2022)

The Economic Burden of Head and Neck Cancer: A Systematic Literature Review
por: Wissinger, Erika, et al.
Publicado: (2014)

Current Advances in Robotics for Head and Neck Surgery—A Systematic Review
por: Boehm, Felix, et al.
Publicado: (2021)

The Prognostic Role of Micro-RNAs in Head and Neck Cancers: An Umbrella Review
por: Mariani, Marco, et al.
Publicado: (2021)

Precision Medicine on the Effects of Microbiota on Head–Neck Diseases and Biomarkers Diagnosis
por: Inchingolo, Angelo Michele, et al.
Publicado: (2023)

The immunotherapeutic role of indoleamine 2,3‐dioxygenase in head and neck squamous cell carcinoma: A systematic review
por: Lin, Daniel J., et al.
Publicado: (2021)

The Prognostic Value of Toll-Like Receptors in Head and Neck Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis
por: Hasnat, Shrabon, et al.
Publicado: (2020)

Oral Microbiota—A New Frontier in the Pathogenesis and Management of Head and Neck Cancers
por: Metsäniitty, Marjut, et al.
Publicado: (2021)

Nasal Cytology Changes in Head and Neck Cancer Treatment: A Systemic Review
por: Riva, Giuseppe, et al.
Publicado: (2023)

Identification of an atypical etiological head and neck squamous carcinoma subtype featuring the CpG island methylator phenotype
por: Brennan, K., et al.
Publicado: (2017)

Comparative efficacy and safety of radiotherapy/cetuximab versus radiotherapy/chemotherapy for locally advanced head and neck squamous cell carcinoma patients: a systematic review of published, primarily non-randomized, data
por: Mei, Mei, et al.
Publicado: (2020)

Immunotherapy in head and neck squamous cell carcinoma and rare head and neck malignancies
por: Cavalieri, Stefano, et al.
Publicado: (2021)

Genomic Immune Evasion: Diagnostic and Therapeutic Opportunities in Head and Neck Squamous Cell Carcinomas
por: Kirtane, Kedar, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_h81k4u50gi7ap3jq78ddqvkspb